Notre Réseau Forum EPN 2012
Ca ce passe maintenant! Forum de l'EPN 2012Le Forum de l'EPN a lieu du 21 au 23 mars 2012, à Addis Ababa, en Ethiopie. Le Forum biennal (le 21 et 22 mars) et l'Assemblée Générale (le 23 mars) sont une opportunité pour les membres de l'EPN de se rencontrer physiquement, de discuter et de prendre des décisions critiques sur les activités du Réseau. Maintenant disponibles sont des réflections sur les événements à Addis.
Le forum a lieu du 21 au 23 mars 2012, à Addis Ababa en Ethiopie au Desalegn hotel (http://www.desalegnhotel.com/). Le thème des discussions est 'l'accès aux médicaments de qualité: besoins de priorité, actions de priorité pour le présent et l'avenir'. Reflections on DAY 1Meeting the Challenges for Access to Quality Medicines Reflections on DAY 2Meeting the Challenges for Access to Quality MedicinesEthiopian Evangelical Church Mekane Yesus Development and Social Services Commission hosting the bi-annual Forum of EPN (Ecumenical Pharmaceutical Network) in Addis AbabaAddis Ababa, Ethiopia – March 22, 2012 – The 2nd day of the EPN Forum looked on drug supply, medicines procurement, local production, and the uprising issue of Non Communicable Diseases (NCD). NCDs are projected to account for more than a quarter of all deaths by 2015 in Africa. Estimates indicate that the increase of deaths from chronic diseases will exceed that from infectious diseases, maternal and prenatal conditions, and nutritional deficiencies more than four‐fold in the next 10 years. Often NCDs are chronic diseases and need a lifelong treatment. Access to chronic disease medicines is required for the fulfilment of MDG 8. Surveys showed that often the availability of medicines for NCDs is lower compared to medicines for acute diseases. That can be overcome relatively easy in terms of planning and supply. Because of the chronic treatment patients have to attend the health facility regularly. So demand and dispensing can be appointed and planned. It also allows to plan capacities within the health institutions. Dr. Rainer Engels, German Society for International Cooperation (GIZ), reported about the holistic approach to promote the pharmaceutical sector, e.g. in Ethiopia. The focus areas are the • support of the regulatory authority in registration and market surveillance • support and development of institutional capacity and elements for setting up a national quality infrastructure in Ethiopia and the EAC region There is also support for the EAC in implementing their regional Pharmaceutical Manufacturing Plan of Action. By creating the Regional Pharmaceutical Associations and the Federation of East African Pharmaceutical Manufacturers (FEAPM) the local production on the continent should be strengthened. The example of CHAN Medi-Pharm demonstrated that licensed production could also be an alternative measure to increase the access of affordable, qualitative medicines. With a process of auditing, product selection, communication, etc. contract manufacturer were selected. They produce 33 essential medicines. CHAN is active in increasing this portfolio. The underutilisation of zinc tablets for children with diarrhoea was posted as a burning issue. Statistics show that despite improvement during the last decade, still too many children die of diarrhoea. The last panel discussion called for action planning to change the situation. Another important aspect raised was the creation of a platform of information sharing for DSOs within EPN on its website. It should allow to exchange analytical quality results, price information, and other experiences in drug procurement. Dr Andreas Wiegand, EPN Reporting from Desalegn Hotel Addis Ababa This e-mail address is being protected from spambots. You need JavaScript enabled to view it +254 724 301755
Programme du forumCliquez ici pour télécharger le programme (à confirmer):
Conférenciers confirmésChristophe Luyckx Institute of Tropical Medicine, Coordinator QUAMED "Quality Medicines for All"
Topic: "Analysing, understanding and addressing the problem of poor quality medicines in low income markets" Bio: After 8 years experience in the field of pharmaceutical marketing and communication, Christophe Luyckx joined the humanitarian sector where he implemented social marketing programs for various NGOs, donors and consultancy offices, aimed at strengthening the impact of central medical stores for generic medicines in developing countries. Christophe has also served as CEO of PSF (Pharmaciens sans Frontières) and PAH (Pharmacie et Aide Humanitaire) and was Marketing Director of an important procurement agency for generic medicines where he developed the procurement channels from China and India. These various assignments and experience in over 20 countries led Christophe to identify the quality of medicines as a major concern for developing countries and encouraged him to join the Institute of Tropical Medicine of Antwerp where he currently coordinates QUAMED « quality of medicine for all ». Christophe holds a master’s degree in Social Communications and a University degree in Public Health and Health Promotion.
Dr Sameh Saleeb Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program (MSH, USAID), Technical Deputy Director
Topic: "Global programmes and access to medicines" Bio: Dr. Sameh Saleeb is the Technical Deputy Director for the SIAPS Program of Management Sciences for Health (MSH) in Arlington, VA. He is a public health doctor with 20 years of experience. Previously, he was the SPS Senior Technical Manager for HIV/AIDS and managed several field programs. Prior to joining MSH, he provided assistance to projects in maternal and child health, reproductive health and HIV/AIDS, malaria control, cost recovery, and health systems reform. Dr. Saleeb’s expertise includes program planning and management, systems development and implementation, pharmaceutical and commodity management systems strengthening, and monitoring and evaluation. He is fluent in Arabic, English, and French.
Matthew O. Azoji CHAN Medi-Pharm Ltd/.Gte, CEO
Topic: Moderator Formal Opening Session Bio: Matthew O. AZOJI, Managing Director/CEO of CHAN Medi-Pharm Ltd/Gte, is a pharmacist with about 25 years experience in sales, marketing, business development, procurement & supply management and strategic/general management in the pharmaceutical and public health sectors of Nigeria.
Dr William Mwatu Gllaxo Smith Kline (GSK), Medical and Regulatory Affairs Director East Africa
Bio: Dr Mwatu, Medical and Regulatory Affairs Director East Africa at GSK has numerous years of experience in the pharma industry. In addition to his many years with GSK, he has worked with Procter and Gamble East Africa and the Ministry of Health in Kenya. Dr Mwato holds an MBA of Newport University and bachelor in Pharmacy from University of Nairobi. He is a member of the steering committee of the African Medicines Harmonization initiative, a member of the National Bioethics committee of Kenya, a member of the Pharmaceutical Association of Kenya and of the Association of Clinical Trial Professionals. He is also the Chair of the Steering committee of the East African Federation of Pharmaceutical Manufacturers and the vice-chair of the Kenya Association of Pharmaceutical Industry.
Marlon Banda Churches Health Association of Zambia (CHAZ), Director of Operations
Topic: "Partnerships with Government to improve access to medicine Case study from CHAZ" Bio: Marlon Banda recently returned to the Churches Health Association of Zambia, where he has been appointed Director of Operations, overseeing CHAZs planning and development, pharmaceutical and logistics services and the James Cairns Training Institute - the organization’s training and capacity building Centre. In his first tenure at CHAZ, Marlon led the establishment of the organization’s pharmaceutical services. From there, he consulted widely for EPN, WHO and DFID in the drug supply management area. He also held various positions at UNICEF Supply Division, John Snow Incorporated and the Global Fund.
Christian Health Association of Kenya (CHAK), General Secretary
Topic: "What have FBO’s done to address the growing need for medicines for Non Communicable Diseases?"
Andreas Wiegand Ecumenical Pharmaceutical Network, programme officer for product development and strategic communication
Topic: "Contribution of faith-based DSOs in SSA on increasing access to medicines" Bio: After studying pharmacy in Freiburg, Germany, Andreas Wiegand first worked in retail pharmacy before exploring transdermal therapeutic systems and the issue of so called nitrate tolerance in a department of clinical pharmacology at a cardiovascular hospital. He joined the German Development Services working in a regional hospital in the North West of Namibia in the 90’s, continued his specialisation in clinical pharmacy in Heidelberg and Dachau afterwards. For the last ten years, Mr Wiegand worked for a generic company in Germany in various functions in the medical department, project management, and regulatory affairs. On the 6th of February, he arrived in Kenya, excited to join the EPN Secretariat in Nairobi.
Deed Jaldessa Kontoma Ethiopian Evangelical Church Mekane Yesus Development and Social Services Commission (EECMY-DASSC), Director
WHO, Department of Medicines Policy and Standards, Coordinator
GIZ, Head Trade Programme
Topic: Lessons from GIZ on promoting pharmaceutical production in Africa
Daniel Ayele GIZ Ethiopia, pharmaceutical sector senior expert
African Union Commission, health officer, MD, MPH
Topic: Formal opening session Bio: Dr. Janet Byaruhanga is a Medical Doctor with a Master’s Degree in Public Health Research obtained from the University of Edinburgh, UK. She has been working as a health officer in the Department of Social Affairs of the African Union Commission since 2007. Dr. Byaruhanga also served in the Ministry of Health of Rwanda both as a general physician as well as a public health expert.
En savoir plus:
|
EPN Forum programme 2012 (
